- Global Pharma News & Resources

Press Releases - 2022-08-04

Date Title Company
04-Aug-2022 SQZ Biotechnologies Reports Second Quarter 2022 Financial Results and Recent Portfolio Updates Businesswire
04-Aug-2022 Puma Biotechnology Reports Second Quarter 2022 Financial Results Businesswire
04-Aug-2022 Aerie Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update Businesswire
04-Aug-2022 Vertex Reports Second Quarter 2022 Financial Results Businesswire
04-Aug-2022 Legend Biotech Appoints Three New Directors and Elects New Chairman of the Board Businesswire
04-Aug-2022 Berry Consultants Transitioning from I-SPY Trials Businesswire
04-Aug-2022 Otsuka Pharmaceutical and Lundbeck present positive results showing reduced agitation in patients with Alzheimer’s dementia treated with brexpiprazole at the 2022 Alzheimer's Association International Conference Businesswire
04-Aug-2022 Global Consumer Healthcare Market Report 2022: Rising E-commerce Sector and Shift from Medical Prescriptions to OTC Drugs Driving Growth - Businesswire
04-Aug-2022 Natural Killer (NK) Cell Therapeutics Market, 2032 - Businesswire
04-Aug-2022 Rituximab Biosimilars Global Market Report 2022: Rising Prevalence of Non-Hodgkin's Lymphoma (NHL) Driving Growth - Businesswire
04-Aug-2022 Global Generic Drugs Market Report (2022-2027): Low Cost of Generic Drugs as Compared to Branded Drugs & Robust M&A Activities in the Generic Drugs Market Driving Growth - Businesswire
04-Aug-2022 Global Manufacturing Execution Systems Market Analysis/Forecast Report 2022-2027 - Businesswire
04-Aug-2022 Microneedle Drug Delivery Systems Market Trend Shows a Rapid Growth Competitive Analysis Future Prospects and Forecast 2030 MARKITWIRED
04-Aug-2022 BioAesthetics Announces Additional Clinical Study for NACgraft Businesswire
04-Aug-2022 Optime Care Receives 2022 Sales and Marketing Technology Award Businesswire
04-Aug-2022 LAMEA Peptide Therapeutics Market Report 2022: Featuring Key Players Eli Lilly And Company, AstraZeneca, Pfizer, GlaxoSmithKline & Others - Businesswire
04-Aug-2022 Applied DNA Announces Pricing of $12 Million Upsized Public Offering, Priced at a Premium to Market Under Nasdaq Rules Businesswire
04-Aug-2022 Abivax phase 3 program with obefazimod in ulcerative colitis progresses with US IRB approval ABIVAX
04-Aug-2022 WestPark Capital Announces Closing of $6.9 Million Initial Public Offering for Mobile Global Esports (NASDAQ:MGAM) Businesswire
04-Aug-2022 India Pressure Swing Adsorption (PSA) Nitrogen Generator Market Outlook 2021-2022 & 2027 - Businesswire